Skip to content
  • ABOUT
        • MISSION/HISTORY
        • DIRECTORS/STAFF
        • SUPPORT
        • INTERNSHIPS
        • FINANCIAL INFORMATION
        • JOBS
        • CONTACT US
  • WASTEWATCHER
  • MEDIA
        • COMMENTARY
        • PRESS RELEASES
        • VIDEOS
  • ISSUES
    • CONGRESSIONAL PIG BOOK
      • EARMARK DATABASE
      • PRIME CUTS
      • ISSUE BRIEFS
      • AGENCY COMMENTS
    • DEFENSE
      • AVIATION & SPACE
      • F-35 JOINT STRIKE FIGHTER
      • PROCUREMENT
    • INNOVATION & TECHNOLOGY POLICY CENTER
      • ANTITRUST
      • ARTIFICIAL INTELLIGENCE
      • BIOPHARMACEUTICALS
      • INTELLECTUAL PROPERTY
      • PRIVACY
      • TECHNOLOGY AND INNOVATION
      • TELECOMMUNICATIONS
    • GENERAL WASTE
      • AGRICULTURE REFORM
      • POSTAL SERVICE
      • TAXES
      • TRANSPORTATION
    • HEALTH AND SCIENCE
      • PRICE CONTROLS
      • GOVERNMENT RUN HEALTHCARE
      • 340B DRUG DISCOUNT PROGRAM
      • PHARMACY BENEFIT MANAGERS
      • TOBACCO HARM REDUCTION
    • STATE ISSUES
  • ITPC
        • ANTITRUST
        • ARTIFICIAL INTELLIGENCE
        • BIOPHARMACEUTICALS
        • INTELLECTUAL PROPERTY
        • PRIVACY
        • TECHNOLOGY AND INNOVATION
        • TELECOMMUNICATIONS
  • CCAGW
DONATE
Facebook X-twitter Icon-instagram-1 Icon-youtube

Health

The Senate Should Not Implement Price Controls on Pharmaceuticals
340B, General Waste, Government Waste, Health, Healthcare, Pharmaceuticals, Taxpayers, Transparency, Waste

WSJ Reinforces Waste and Abuse in Healthcare

September 24, 2025 Alec Mena

Federal healthcare programs are often well-intended but end up costing more than expected and become subject to waste, fraud, abuse, and mismanagement.  One of the best (or worst) examples of such a result is the 340B Drug Pricing Program, which is administered by the Health Resources and Services Administration (HRSA).  The lack of clear intent […]

340B, Biopharmaceuticals, Congress, General Waste, Health, Healthcare

Senate HELP Committee Hearing Highlights Need to Reform 340B

August 13, 2025 Eric Maus

The 340B Drug Discount Program was created in 1992 to help federally funded clinics and public hospitals that serve a large uninsured population cover the cost of drugs and provide discounts to patients.  But the lack of guardrails on the program and failure to define a patient has led to it being abused by hospitals […]

340B, Biopharmaceuticals, Corporate Welfare, General Waste, Government Waste, Health, Healthcare, Medicare/aid, Pharmaceuticals, Reform, Regulation, Regulations, States, Waste

Markwayne Mullin Wants to Make 340B Work for Oklahomans

August 8, 2025 Alec Mena

The federal 340B Drug Pricing Program was intended to provide discounts on drugs to patients but the lack of a clear intent and patient definition, along with inadequate oversight, has led to the program being exploited by hospitals and contract pharmacies to generate millions of dollars in profit.  The discounts are supposed to be provided […]

tobacco harm reduction; flavor bans; vaping, General Waste, Health, Healthcare

Fighting the Good Fight on World Vape Day

May 30, 2025 Eric Maus

Vaping and other tobacco harm reduction (THR) products have improved the health of millions of people by helping them stop smoking traditional cigarettes.  On World Vape Day, May 30, 2025, supporters of THR should use this occasion to continue this momentum and fight against the barriers that restrict access to such products. THR products have […]

Search

Citizens Against Government Waste works to eliminate waste, fraud, abuse, and mismanagement in government through research and public education.

  • ABOUT
  • WASTEWATCHER
  • MEDIA CENTER
  • ISSUES
  • ITPC
  • CCAGW
  • 1-800-USA-DEBT ®
  • MEDIA@CAGW.ORG
  • 317 MASSACHUSETTS AVENUE, N.E.
    SUITE 300
    WASHINGTON, D.C. 20002

© Citizens Against Government Waste